Unknown

Dataset Information

0

Metabolomics and proteomics identify the toxic form and the associated cellular binding targets of the anti-proliferative drug AICAR.


ABSTRACT: 5-Aminoimidazole-4-carboxamide 1-?-d-ribofuranoside (AICAR, or acadesine) is a precursor of the monophosphate derivative 5-amino-4-imidazole carboxamide ribonucleoside 5'-phosphate (ZMP), an intermediate in de novo purine biosynthesis. AICAR proved to have promising anti-proliferative properties, although the molecular basis of its toxicity is poorly understood. To exert cytotoxicity, AICAR needs to be metabolized, but the AICAR-derived toxic metabolite was not identified. Here, we show that ZMP is the major toxic derivative of AICAR in yeast and establish that its metabolization to succinyl-ZMP, ZDP, or ZTP (di- and triphosphate derivatives of AICAR) strongly reduced its toxicity. Affinity chromatography identified 74 ZMP-binding proteins, including 41 that were found neither as AMP nor as AICAR or succinyl-ZMP binders. Overexpression of karyopherin-? Kap123, one of the ZMP-specific binders, partially rescued AICAR toxicity. Quantitative proteomic analyses revealed 57 proteins significantly less abundant on nuclei-enriched fractions from AICAR-fed cells, this effect being compensated by overexpression of KAP123 for 15 of them. These results reveal nuclear protein trafficking as a function affected by AICAR.

SUBMITTER: Douillet DC 

PROVIDER: S-EPMC6341394 | biostudies-literature | 2019 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Metabolomics and proteomics identify the toxic form and the associated cellular binding targets of the anti-proliferative drug AICAR.

Douillet Delphine C DC   Pinson Benoît B   Ceschin Johanna J   Hürlimann Hans C HC   Saint-Marc Christelle C   Laporte Damien D   Claverol Stéphane S   Konrad Manfred M   Bonneu Marc M   Daignan-Fornier Bertrand B  

The Journal of biological chemistry 20181126 3


5-Aminoimidazole-4-carboxamide 1-β-d-ribofuranoside (AICAR, or acadesine) is a precursor of the monophosphate derivative 5-amino-4-imidazole carboxamide ribonucleoside 5'-phosphate (ZMP), an intermediate in <i>de novo</i> purine biosynthesis. AICAR proved to have promising anti-proliferative properties, although the molecular basis of its toxicity is poorly understood. To exert cytotoxicity, AICAR needs to be metabolized, but the AICAR-derived toxic metabolite was not identified. Here, we show t  ...[more]

Similar Datasets

| S-EPMC307585 | biostudies-literature
| S-EPMC7663932 | biostudies-literature
| S-EPMC3202559 | biostudies-literature
| S-EPMC10641761 | biostudies-literature
| S-EPMC4007108 | biostudies-literature
| S-EPMC7153277 | biostudies-literature
| S-EPMC6748436 | biostudies-literature
| S-EPMC5983596 | biostudies-literature
| S-EPMC5795392 | biostudies-literature
| S-EPMC1626102 | biostudies-literature